Molina Healthcare, Inc. (NYSE:MOH) Receives $393.09 Average Target Price from Analysts

Molina Healthcare, Inc. (NYSE:MOH) has been assigned a consensus recommendation of “Hold” from the nine analysts that are presently covering the firm, Marketbeat Ratings reports. One analyst has rated the stock with a sell recommendation, four have issued a hold recommendation and four have issued a buy recommendation on the company. The average 1 year target price among analysts that have covered the stock in the last year is $393.09.

Several analysts have commented on the stock. Truist Financial lifted their price objective on shares of Molina Healthcare from $435.00 to $460.00 and gave the company a “buy” rating in a research note on Tuesday, February 20th. StockNews.com cut shares of Molina Healthcare from a “strong-buy” rating to a “buy” rating in a research note on Thursday, February 8th. Bank of America cut shares of Molina Healthcare from a “neutral” rating to an “underperform” rating and set a $439.00 target price for the company. in a research note on Thursday, March 28th. Barclays began coverage on shares of Molina Healthcare in a research note on Wednesday, March 6th. They issued an “equal weight” rating and a $437.00 target price for the company. Finally, Cantor Fitzgerald reiterated an “overweight” rating and issued a $406.00 target price on shares of Molina Healthcare in a research note on Thursday, April 4th.

Insider Buying and Selling

In related news, CFO Mark Lowell Keim sold 15,000 shares of the business’s stock in a transaction on Monday, February 12th. The shares were sold at an average price of $386.56, for a total value of $5,798,400.00. Following the completion of the sale, the chief financial officer now owns 36,531 shares of the company’s stock, valued at approximately $14,121,423.36. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. In related news, Director Richard M. Schapiro sold 711 shares of the business’s stock in a transaction on Monday, February 12th. The shares were sold at an average price of $384.06, for a total value of $273,066.66. Following the completion of the sale, the director now owns 12,207 shares of the company’s stock, valued at approximately $4,688,220.42. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, CFO Mark Lowell Keim sold 15,000 shares of the business’s stock in a transaction on Monday, February 12th. The stock was sold at an average price of $386.56, for a total transaction of $5,798,400.00. Following the completion of the sale, the chief financial officer now directly owns 36,531 shares of the company’s stock, valued at approximately $14,121,423.36. The disclosure for this sale can be found here. In the last quarter, insiders sold 16,711 shares of company stock valued at $6,472,517. 1.11% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On Molina Healthcare

A number of large investors have recently modified their holdings of MOH. Annis Gardner Whiting Capital Advisors LLC purchased a new stake in shares of Molina Healthcare during the third quarter worth $30,000. McIlrath & Eck LLC purchased a new stake in shares of Molina Healthcare during the fourth quarter worth $34,000. VisionPoint Advisory Group LLC grew its holdings in shares of Molina Healthcare by 105.6% during the third quarter. VisionPoint Advisory Group LLC now owns 111 shares of the company’s stock worth $36,000 after buying an additional 57 shares in the last quarter. Raleigh Capital Management Inc. grew its holdings in shares of Molina Healthcare by 40.4% during the third quarter. Raleigh Capital Management Inc. now owns 125 shares of the company’s stock worth $41,000 after buying an additional 36 shares in the last quarter. Finally, Principal Securities Inc. purchased a new stake in shares of Molina Healthcare during the fourth quarter worth $42,000. Hedge funds and other institutional investors own 98.50% of the company’s stock.

Molina Healthcare Stock Performance

Shares of NYSE MOH opened at $362.03 on Friday. The company has a current ratio of 1.54, a quick ratio of 1.54 and a debt-to-equity ratio of 0.57. Molina Healthcare has a 12 month low of $266.35 and a 12 month high of $423.92. The company has a 50 day simple moving average of $394.33 and a two-hundred day simple moving average of $371.60. The stock has a market cap of $21.21 billion, a price-to-earnings ratio of 19.28, a PEG ratio of 1.03 and a beta of 0.47.

Molina Healthcare (NYSE:MOH) last announced its quarterly earnings data on Wednesday, February 7th. The company reported $4.38 EPS for the quarter, beating the consensus estimate of $4.31 by $0.07. Molina Healthcare had a net margin of 3.20% and a return on equity of 32.34%. The business had revenue of $9.05 billion during the quarter, compared to analysts’ expectations of $8.35 billion. During the same period in the previous year, the business posted $4.10 EPS. The business’s quarterly revenue was up 10.0% compared to the same quarter last year. As a group, analysts predict that Molina Healthcare will post 23.62 earnings per share for the current year.

Molina Healthcare Company Profile

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.